Sinopharm
1099.HK
#2002
Rank
S$10.81 B
Marketcap
$3.47
Share price
-2.43%
Change (1 day)
1.03%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Market capitalization of Sinopharm (1099.HK)

Market cap: S$10.81 Billion

As of November 2024 Sinopharm has a market cap of S$10.81 Billion. This makes Sinopharm the world's 2002th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Sinopharm from 2009 to 2024

End of year Market Cap

Year Marketcap Change
2024S$10.81 B0.25%
2023S$10.79 B1.34%
2022S$10.65 B16.07%
2021S$9.17 B-3.86%
2020S$9.54 B-34.79%
2019S$14.63 B-14.19%
2018S$17.05 B6.58%
2017S$16.00 B-3.01%
2016S$16.49 B5.05%
2015S$15.70 B21.38%
2014S$12.93 B38.59%
2013S$9.33 B1.57%
2012S$9.19 B23.05%
2011S$7.47 B-26.46%
2010S$10.15 B-10.08%
2009S$11.29 B